Biotech is entering a new chapter. As announced by Commission President Ursula von der Leyen, the EU Biotech Act is set to become a cornerstone of Europe’s strategy to boost innovation, biomanufacturing and sustainable growth. But how can we turn that ambition into concrete opportunities for innovation, investment, and impact? What does this mean for Belgium’s thriving biotech and biopharma ecosystem? And how can our sector seize the opportunities this bold initiative offers?
Join us at the bio.be/essenscia annual event, a unique gathering of biotech and biopharma leaders, policymakers, academics, diplomats and key stakeholders, to explore what this new EU initiative could mean for our sector and how Belgium can take a leading role.
European Commissioner Várhelyi and Belgian Minister of Foreign and European Affairs Prévot will share their reflections, highlighting the strategic importance of biotechnology and the opportunities it presents for Europe and Belgium.